Cleaning validation is critical to the pharmaceutical industry, ensuring that risks of contamination, product carry over, and cross contamination are controlled, minimized, and monitored to maintain patient safety and product quality. Today we will discuss the lifecycle approach to cleaning validation, and the importance of creating cGMP approved cleaning programs that encompass the applications, methods and controls necessary for creation and launch of compliant cleaning programs that meet or exceed regulatory expectations.  In this episode we remind listeners about the importance of formalized cleaning programs, and best practices around cleaning activities, sampling and testing.

Life Cycle Approach to Cleaning Validation

On this episode we go back to basics and get some facts straight. All processes and products come with some level of inherent risk. In life sciences, the goal is always to reduce risk as much as possible ensuring patient safety to the maximum extent. This systematic process for the assessment, controls, communication, and review of risks across the product life-cycle is the focus of this new series of podcasts called Risk Revolution. Take a listen as we take a look at risk management in the broader context and get some facts straight about the roles of quality professionals, supply chain, supply chain mapping and crisis planning, risk assessments and much more.

Risk Revolution - Let's Get Some QRM Facts Straight!

Digital transformation in the pharmaceutical industry is crucial for better patient care, cost-effectiveness, greater transparency, improved production, and drug development. Across the pharmaceutical industry, companies are at varying stages in the adoption of digital technologies, but it is clear that the recent COVID pandemic may have accelerated this process for all by about 3 to 4 years. On this episode of Voices in Validation we speak with our guest Chinmoy Roy about the current state of digital transformation across the pharmaceutical industry, and what companies are doing to move toward a strategic digital transformation plan.

This track is not available anymore.

Other tracks from Informa Connect Life Sciences - BPI